Standards; Pharmaceutical/API Drug Impurities/Metabolites; Anti-virals/Anti-retrovirals;
應用
EIDD 1931 is an orally bioavailable broad-spectrum antiviral that inhibits SARS-CoV-2 and other multiple endemic, epidemic and bat coronavirus and has the potential for seasonal and pandemic influenza treatment. A broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses.
參考文獻
Sheahan, T. P., et al.: Sci. Transl. Med., 12, eabb5883 (2020); Agostini, M. L., et al.: J. Virol., 93, 01348 (2019); Yoon, J., et al.: Antimicrob. Agents and Chemother., 62, 00766 (2018); Barnard, D. L., et al.: Antivir. Chem. Chemother., 17, 275 (2006)
滬ICP備17019645號
400-821-0725
